Study finds a lower dose of COVID-19 drug is effective, and allows treatment for more patients - Medical Xpress

Many countries around the world are experiencing shortages of tocilizumab, an immunosuppressive drug that has become the standard of care for treating severe cases of COVID-19. A new study co-led by researchers at Yale and the University of British Columbia, …

Many countries around the world are experiencing shortages of tocilizumab, an immunosuppressive drug that has become the standard of care for treating severe cases of COVID-19. A new study co-led by … [+5006 chars]

full article...